CytoSorbents Corporation
(NASDAQ : CTSO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading CTSO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
BCRC. R. Bard, Inc.
0.73%307.821.6%$420.79m
ABTAbbott Laboratories
0.00%43.650.8%$303.99m
ISRGIntuitive Surgical, Inc.
-0.08%835.877.5%$303.78m
MDTMedtronic PLC
-0.06%83.080.6%$300.49m
BDXBecton, Dickinson and Company
2.47%187.061.3%$288.66m
TMOThermo Fisher Scientific Inc.
-0.85%165.281.0%$272.30m
BSXBoston Scientific Corporation
0.78%26.391.1%$204.45m
BAXBaxter International Inc.
0.47%55.681.7%$202.35m
EWEdwards Lifesciences Corporation
0.01%109.681.2%$201.37m
SYKStryker Corporation
0.74%136.371.3%$138.99m
ZBHZimmer Biomet Holdings, Inc.
1.27%119.601.7%$132.37m
ALGNAlign Technology, Inc.
12.10%134.626.2%$109.43m
HOLXHologic, Inc.
1.28%45.151.6%$99.88m
VARVarian Medical Systems, Inc.
1.97%90.778.8%$98.62m
IDXXIDEXX Laboratories, Inc.
3.05%167.733.7%$95.19m

Company Profile

CytoSorbents Corp. is a critical care immunotherapy company, which engages in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Its products include cytosorb, contrastsorb, vetresq, hemodefend, and drugsorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.